Across TCGA pan-cancer cohorts, RNU6-800P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RNU6-800P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney chromophobe (KICH), where RNU6-800P RNA is repressed in tumor relative to normal tissue. In most cancer types RNU6-800P is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.

KICH, STAD, and BLCA are the cancer types where RNU6-800P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU6-800P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KICH	Female	II,III,IV	−0.315	.015	3	view →
STAD	All	III,IV	+0.493	.023	2	view →
BLCA	Female	III,IV	+0.574	.023	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: RNU6-800P RNA expression & survival · all RNU6-800P data types